Literature DB >> 29868998

Impact of Behavioral Drug Abuse Treatment on Sexual Risk Behaviors: An Integrative Data Analysis of Eight Trials Conducted Within the National Drug Abuse Treatment Clinical Trials Network.

Jennifer L Brown1, Michael D Eriksen2, Nicole K Gause3, Gene H Brody4,5, Jessica M Sales4,5.   

Abstract

The extent to which behavioral drug abuse treatments affect sexual risk behaviors is largely unknown. This study examined the impact of behavioral drug abuse treatments on sexual risk behaviors using an integrative data analysis approach across eight trials conducted within the National Drug Abuse Treatment Clinical Trials Network (CTN). Participants (N = 1305) from eight randomized controlled trials who were sexually active at baseline were included in the pooled dataset; 48.7% were female, 64.1% self-identified as a racial/ethnic minority, with M (SD) age of 34.9 (9.6). Longitudinal logistic regression estimated the probability of risky sexual behavior (i.e., inconsistent condom use and/or > 1 sexual partner in past 30 days) post-intervention with an indicator variable (1 for post-intervention), study condition (control, intervention), and their interaction as predictors; the analysis employed random effects for each trial and included relevant control variables. Time-varying differences in effects based on weeks post-intervention were incorporated using interacted linear and quadratic terms with condition status. Approximately 84.2% reported risky sexual behaviors at baseline. The control and intervention conditions were 18.5 and 17.3 percentage points less likely to report risky sexual behavior post-intervention, respectively. Results suggest decreasing rates of risky sex engagement until 8 weeks (control) or 9 weeks (intervention) post-intervention; risky sexual behavior subsequently increased. Behavioral CTN trial participation was associated with decreased sexual risk behaviors in both the intervention and control trial conditions. Participation in behavioral substance use treatment may result in secondary benefits of sexual risk behavior reductions.

Entities:  

Keywords:  Behavioral drug treatment; Integrative data analysis; Sexual risk behaviors

Mesh:

Year:  2018        PMID: 29868998      PMCID: PMC6050101          DOI: 10.1007/s11121-018-0913-6

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  35 in total

1.  A motivational perspective on risky behaviors: the role of personality and affect regulatory processes.

Authors:  M L Cooper; V B Agocha; M S Sheldon
Journal:  J Pers       Date:  2000-12

2.  Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.

Authors:  M L Prendergast; D Urada; D Podus
Journal:  J Consult Clin Psychol       Date:  2001-06

3.  Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents.

Authors:  Michael S Robbins; Daniel J Feaster; Viviana E Horigian; Michael Rohrbaugh; Varda Shoham; Ken Bachrach; Michael Miller; Kathleen A Burlew; Candy Hodgkins; Ibis Carrion; Nancy Vandermark; Eric Schindler; Robert Werstlein; José Szapocznik
Journal:  J Consult Clin Psychol       Date:  2011-10-03

4.  Short and long views of integrative data analysis: comments on contributions to the special issue.

Authors:  Patrick E Shrout
Journal:  Psychol Methods       Date:  2009-06

5.  Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.

Authors:  Steven Shoptaw; Cathy J Reback; James A Peck; Xiaowei Yang; Erin Rotheram-Fuller; Sherry Larkins; Rosemary C Veniegas; Thomas E Freese; Christopher Hucks-Ortiz
Journal:  Drug Alcohol Depend       Date:  2004-11-28       Impact factor: 4.492

6.  Depression, stress, and social support as predictors of high-risk sexual behaviors and STIs in young women.

Authors:  Kathryn E Mazzaferro; Pamela J Murray; Roberta B Ness; Debra C Bass; Nadra Tyus; Robert L Cook
Journal:  J Adolesc Health       Date:  2006-07-10       Impact factor: 5.012

7.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

8.  Integrative data analysis: the simultaneous analysis of multiple data sets.

Authors:  Patrick J Curran; Andrea M Hussong
Journal:  Psychol Methods       Date:  2009-06

9.  Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysis.

Authors:  Brandon D L Marshall; Evan Wood; Jean A Shoveller; Thomas L Patterson; Julio S G Montaner; Thomas Kerr
Journal:  BMC Public Health       Date:  2011-01-07       Impact factor: 3.295

10.  HIV risk reduction among detained adolescents: a randomized, controlled trial.

Authors:  Angela D Bryan; Sarah J Schmiege; Michelle R Broaddus
Journal:  Pediatrics       Date:  2009-11-09       Impact factor: 9.703

View more
  1 in total

1.  An application of agent-based modeling to explore the impact of decreasing incarceration rates and increasing drug treatment access on sero-discordant partnerships among people who inject drugs.

Authors:  Sabriya L Linton; Don C Des Jarlais; Joseph T Ornstein; Matt Kasman; Ross Hammond; Behzad Kianian; Justin C Smith; Mary E Wolfe; Zev Ross; Danielle German; Colin Flynn; Henry F Raymond; R Monina Klevens; Emma Spencer; John-Mark Schacht; Teresa Finlayson; Gabriela Paz-Bailey; Cyprian Wejnert; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2021-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.